All Pathways
Emergency MedicineEmergency

Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus)

Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus): Suspected DKA → Confirm DKA Diagnosis → Assess DKA Severity → 1. IV Fluid Resuscitation...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected DKA

    Hyperglycemia + Ketosis + Acidosis

    1. Action

      Confirm DKA Diagnosis

      Check diagnostic criteria

      • Glucose: typically >250 mg/dL (may be lower in euglycemic DKA)
      • pH <7.3 and/or HCO3 <18 mEq/L
      • Ketones: β-hydroxybutyrate >3.0 mmol/L or urine ketones moderate-large
      • Anion gap >10-12
      • Consider euglycemic DKA if on SGLT2 inhibitor
      1. Decision

        Assess DKA Severity

        Mild/Moderate vs Severe

        • MILD: pH 7.25-7.30, HCO3 15-18, alert
        • MODERATE: pH 7.0-7.24, HCO3 10-14, alert/drowsy
        • SEVERE: pH <7.0, HCO3 <10, stupor/coma
        1. Action

          1. IV Fluid Resuscitation

          Start immediately - do not delay for insulin

          • 0.9% NaCl: 1-1.5 L in first hour (15-20 mL/kg)
          • Then 250-500 mL/hr based on hydration status
          • Switch to 0.45% NaCl if corrected Na+ normal/elevated
          • Add D5 when glucose <200 mg/dL
          • Typical deficit: 3-6 liters
          1. Decision

            Serum K+ Level?

            Check K+ BEFORE starting insulin

            • Total body K+ depleted despite serum level
            • K+ will drop rapidly with insulin therapy
            1. Warning

              K+ <3.3 mEq/L

              HOLD INSULIN until K+ ≥3.3

              • Replace K+ aggressively (20-40 mEq/hr)
              • Cardiac monitoring essential
              • Recheck K+ every 1-2 hours
              • DO NOT give insulin until K+ ≥3.3
              1. Action

                2. Insulin Therapy

                Start after fluid bolus and K+ assessment

                • Regular insulin IV: 0.1 units/kg bolus, then 0.1 units/kg/hr
                • OR 0.14 units/kg/hr continuous (no bolus)
                • Target glucose drop: 50-70 mg/dL/hr
                • If glucose not falling, double rate
                • When glucose <200, reduce to 0.02-0.05 units/kg/hr + D5
                1. Decision

                  pH <6.9?

                  Consider bicarbonate only in severe acidosis

                  1. Action

                    Bicarbonate Therapy

                    For pH <6.9 only (controversial)

                    • 100 mEq NaHCO3 in 400 mL water + 20 mEq KCl
                    • Infuse over 2 hours
                    • Repeat if pH still <7.0
                    • NOT recommended if pH ≥6.9
                    1. Action

                      Ongoing Monitoring

                      Frequent labs and clinical assessment

                      • BMP: every 2-4 hours initially
                      • Glucose: every 1 hour
                      • β-hydroxybutyrate: every 2-4 hours (preferred over anion gap)
                      • Venous pH: every 2-4 hours until stable
                      • Fluid balance, urine output, mental status
                      1. Action

                        Identify Precipitant

                        The 5 I's and other causes

                        • Infection (UTI, pneumonia, skin)
                        • Infarction (MI, stroke)
                        • Insulin omission/non-adherence
                        • Intoxication (alcohol, drugs)
                        • Infant (pregnancy)
                        • Also: new-onset T1DM, pancreatitis, meds (steroids, SGLT2i)
                      2. Decision

                        DKA Resolution?

                        All criteria must be met

                        • Glucose <200 mg/dL
                        • Anion gap <12 OR β-hydroxybutyrate <0.6 mmol/L
                        • pH ≥7.3 and HCO3 ≥15
                        • Patient able to eat
                        1. Action

                          Transition to SubQ Insulin

                          Overlap IV and SubQ by 1-2 hours

                          • Give basal insulin (glargine/detemir) 1-2 hrs before stopping drip
                          • Calculate total daily dose based on drip rate
                          • Resume home regimen if appropriate
                          • NEW diagnosis: 0.5-0.8 units/kg/day total
                          • Identify and treat precipitant
                          1. Outcome

                            DKA Resolved

                            Continue monitoring, diabetes education

            2. Action

              K+ 3.3-5.3 mEq/L

              Add K+ to fluids + start insulin

              • Add 20-30 mEq KCl per liter of fluid
              • Target K+ 4-5 mEq/L
              • Monitor K+ every 2-4 hours
            3. Action

              K+ >5.3 mEq/L

              Hold K+, start insulin, recheck frequently

              • Do not add K+ to fluids initially
              • K+ will drop with insulin/fluids
              • Recheck every 2 hours
              • ECG monitoring
        2. Outcome

          Complicated Course

          ICU for severe DKA, cerebral edema, ARDS

Guideline Source

Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Scientific Statement From the American Diabetes Association, European Association for the Study of Diabetes, and the Joint British Diabetes Societies

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Fluid rates may need adjustment in elderly, cardiac, or renal disease
  • Insulin sensitivity varies - monitor closely and adjust
  • Cerebral edema risk in children/young adults - different protocols apply
  • Euglycemic DKA (SGLT2i-related) may have normal glucose
  • Concurrent HHS may require modified approach

Applicable Regions

USEUUKInternational

EU: EASD concordant; fixed-rate insulin infusion (FRII) used in some centers

UK: JBDS protocol uses FRII at 0.1 units/kg/hr; emphasizes ketone monitoring

US: ADA guidelines; insulin and potassium protocols standard

International: Adapt to local insulin availability; frequent K+ monitoring critical

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus)?

The Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus) is a emergency clinical algorithm for Emergency Medicine. It provides a structured decision tree to guide clinical decision-making, based on Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Scientific Statement From the American Diabetes Association, European Association for the Study of Diabetes, and the Joint British Diabetes Societies.

What guideline is the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus) based on?

This algorithm is based on Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Scientific Statement From the American Diabetes Association, European Association for the Study of Diabetes, and the Joint British Diabetes Societies (DOI: 10.2337/dci24-0032).

What are the limitations of the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus)?

Known limitations include: Fluid rates may need adjustment in elderly, cardiac, or renal disease; Insulin sensitivity varies - monitor closely and adjust; Cerebral edema risk in children/young adults - different protocols apply; Euglycemic DKA (SGLT2i-related) may have normal glucose; Concurrent HHS may require modified approach. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Diabetic Ketoacidosis Management (ADA/EASD/JBDS 2024 Consensus) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free